Anomalous NLRP3 inflammasome activation is linked with the development of many diseases, especially age-associated ailments for example various metabolic syndromes and metabolic disorders including gout (16), atherosclerosis (35), Alzheimer's disease (AD) (11), and type II diabetes (T2D) (36). Here, NLRP3 is linked to type 2 diabetes mellitus.